164 related articles for article (PubMed ID: 8851291)
1. [Gene therapy of neurologic diseases. Experimental approaches and clinical perspectives].
Isenmann S; Bähr M; Dichgans J
Nervenarzt; 1996 Feb; 67(2):91-108. PubMed ID: 8851291
[TBL] [Abstract][Full Text] [Related]
2. Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's disease.
Kang UJ; Nakamura K
Ann Neurol; 2003; 54 Suppl 6():S103-9. PubMed ID: 12891660
[TBL] [Abstract][Full Text] [Related]
3. Towards gene therapy in the nervous system.
Doering LC
Clin Neurosci; 1995-1996; 3(5):259-61. PubMed ID: 8914791
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
During MJ; Leone P
Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer therapy for neurodegenerative disorders.
Feigin A; Eidelberg D
Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
[TBL] [Abstract][Full Text] [Related]
6. Prospects of treating neurological diseases by gene therapy.
Lundstrom K
Curr Opin Investig Drugs; 2007 Jan; 8(1):34-40. PubMed ID: 17263183
[TBL] [Abstract][Full Text] [Related]
7. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.
Wyman T; Rohrer D; Kirigiti P; Nichols H; Pilcher K; Nilaver G; Machida C
Gene Ther; 1999 Oct; 6(10):1648-60. PubMed ID: 10516713
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
[TBL] [Abstract][Full Text] [Related]
9. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
10. From gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.
Poenaru L
Ann Med; 2001 Feb; 33(1):28-36. PubMed ID: 11310936
[TBL] [Abstract][Full Text] [Related]
11. Application of ex vivo gene therapy in the treatment of Parkinson's disease.
Raymon HK; Thode S; Gage FH
Exp Neurol; 1997 Mar; 144(1):82-91. PubMed ID: 9126156
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of RNA interference for neurological disorders.
Sah DW
Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477
[TBL] [Abstract][Full Text] [Related]
14. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors.
Sabaté O; Barkats M; Buc-Caron MH; Castel-Barthe MN; Finiels F; Horellou P; Revah F; Mallet J
Clin Neurosci; 1995-1996; 3(5):317-21. PubMed ID: 8914799
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy in the CNS.
Costantini LC; Bakowska JC; Breakefield XO; Isacson O
Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
19. [Prospects for gene therapy in hematology].
Moreau-Gaudry F; Mazurier F; Salesse S; Fontanellas A; Verneuil HD
Ann Biol Clin (Paris); 1999; 57(1):43-50. PubMed ID: 9920966
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biology in neurology].
Borasio GD; Gasser T; Brandt T
Internist (Berl); 1994 Feb; 35(2):163-71. PubMed ID: 8150582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
